Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study
Abstract Extracorporeal membrane oxygenation (ECMO) support has a high incidence of both bleeding and thrombotic complications. Despite clear differences in patient characteristics and pathologies between veno-venous (VV) and veno-arterial (VA) ECMO support, anticoagulation practices are often the s...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/80fff7a6ca744bc7833b4f6b3fafec50 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:80fff7a6ca744bc7833b4f6b3fafec50 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:80fff7a6ca744bc7833b4f6b3fafec502021-12-02T14:26:16ZHemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study10.1038/s41598-021-87026-z2045-2322https://doaj.org/article/80fff7a6ca744bc7833b4f6b3fafec502021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87026-zhttps://doaj.org/toc/2045-2322Abstract Extracorporeal membrane oxygenation (ECMO) support has a high incidence of both bleeding and thrombotic complications. Despite clear differences in patient characteristics and pathologies between veno-venous (VV) and veno-arterial (VA) ECMO support, anticoagulation practices are often the same across modalities. Moreover, there is very little data on their respective coagulation profiles and comparisons of thrombin generation in these patients. This study compares the coagulation profile and thrombin generation between patients supported with either VV and VA ECMO. A prospective cohort study of patients undergoing VA and VV ECMO at an Intensive care department of a university hospital and ECMO referral centre. In addition to routine coagulation testing and heparin monitoring per unit protocol, thromboelastography (TEG), multiplate aggregometry (MEA), calibrated automated thrombinography (CAT) and von-Willebrand’s activity (antigen and activity ratio) were sampled second-daily for 1 week, then weekly thereafter. VA patients had significantly lower platelets counts, fibrinogen, anti-thrombin and clot strength with higher d-dimer levels than VV patients, consistent with a more pronounced consumptive coagulopathy. Thrombin generation was higher in VA than VV patients, and the heparin dose required to suppress thrombin generation was lower in VA patients. There were no significant differences in total bleeding or thrombotic event rates between VV and VA patients when adjusted for days on extracorporeal support. VA patients received a lower median daily heparin dose 8500 IU [IQR 2500–24000] versus VV 28,800 IU [IQR 17,300–40,800.00]; < 0.001. Twenty-eight patients (72%) survived to hospital discharge; comprising 53% of VA patients and 77% of VV patients. Significant differences between the coagulation profiles of VA and VV patients exist, and anticoagulation strategies for patients of these modalities should be different. Further research into the development of tailored anticoagulation strategies that include the mode of ECMO support need to be completed.Bruce CartwrightHannah M. BruceGeoffrey KershawNancy CaiJad OthmanDavid GattasJacqueline L. RobsonSarah HayesHayden AlicajicAnna HinesAlice WhyteNophanan ChaikittisilpaTimothy James SouthwoodPaul ForrestRichard J. TotaroPaul G. BannonScott DunkleyVivien M. ChenMark DennisNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Bruce Cartwright Hannah M. Bruce Geoffrey Kershaw Nancy Cai Jad Othman David Gattas Jacqueline L. Robson Sarah Hayes Hayden Alicajic Anna Hines Alice Whyte Nophanan Chaikittisilpa Timothy James Southwood Paul Forrest Richard J. Totaro Paul G. Bannon Scott Dunkley Vivien M. Chen Mark Dennis Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| description |
Abstract Extracorporeal membrane oxygenation (ECMO) support has a high incidence of both bleeding and thrombotic complications. Despite clear differences in patient characteristics and pathologies between veno-venous (VV) and veno-arterial (VA) ECMO support, anticoagulation practices are often the same across modalities. Moreover, there is very little data on their respective coagulation profiles and comparisons of thrombin generation in these patients. This study compares the coagulation profile and thrombin generation between patients supported with either VV and VA ECMO. A prospective cohort study of patients undergoing VA and VV ECMO at an Intensive care department of a university hospital and ECMO referral centre. In addition to routine coagulation testing and heparin monitoring per unit protocol, thromboelastography (TEG), multiplate aggregometry (MEA), calibrated automated thrombinography (CAT) and von-Willebrand’s activity (antigen and activity ratio) were sampled second-daily for 1 week, then weekly thereafter. VA patients had significantly lower platelets counts, fibrinogen, anti-thrombin and clot strength with higher d-dimer levels than VV patients, consistent with a more pronounced consumptive coagulopathy. Thrombin generation was higher in VA than VV patients, and the heparin dose required to suppress thrombin generation was lower in VA patients. There were no significant differences in total bleeding or thrombotic event rates between VV and VA patients when adjusted for days on extracorporeal support. VA patients received a lower median daily heparin dose 8500 IU [IQR 2500–24000] versus VV 28,800 IU [IQR 17,300–40,800.00]; < 0.001. Twenty-eight patients (72%) survived to hospital discharge; comprising 53% of VA patients and 77% of VV patients. Significant differences between the coagulation profiles of VA and VV patients exist, and anticoagulation strategies for patients of these modalities should be different. Further research into the development of tailored anticoagulation strategies that include the mode of ECMO support need to be completed. |
| format |
article |
| author |
Bruce Cartwright Hannah M. Bruce Geoffrey Kershaw Nancy Cai Jad Othman David Gattas Jacqueline L. Robson Sarah Hayes Hayden Alicajic Anna Hines Alice Whyte Nophanan Chaikittisilpa Timothy James Southwood Paul Forrest Richard J. Totaro Paul G. Bannon Scott Dunkley Vivien M. Chen Mark Dennis |
| author_facet |
Bruce Cartwright Hannah M. Bruce Geoffrey Kershaw Nancy Cai Jad Othman David Gattas Jacqueline L. Robson Sarah Hayes Hayden Alicajic Anna Hines Alice Whyte Nophanan Chaikittisilpa Timothy James Southwood Paul Forrest Richard J. Totaro Paul G. Bannon Scott Dunkley Vivien M. Chen Mark Dennis |
| author_sort |
Bruce Cartwright |
| title |
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| title_short |
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| title_full |
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| title_fullStr |
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| title_full_unstemmed |
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study |
| title_sort |
hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the hectic study |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/80fff7a6ca744bc7833b4f6b3fafec50 |
| work_keys_str_mv |
AT brucecartwright hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT hannahmbruce hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT geoffreykershaw hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT nancycai hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT jadothman hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT davidgattas hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT jacquelinelrobson hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT sarahhayes hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT haydenalicajic hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT annahines hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT alicewhyte hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT nophananchaikittisilpa hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT timothyjamessouthwood hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT paulforrest hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT richardjtotaro hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT paulgbannon hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT scottdunkley hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT vivienmchen hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy AT markdennis hemostasiscoagulationandthrombininvenoarterialandvenovenousextracorporealmembraneoxygenationthehecticstudy |
| _version_ |
1718391377996283904 |